AMED

Amedisys
AMED

Overview Fund Activity
Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

284 hedge funds and large institutions have $3.05B invested in Amedisys in 2022 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 106 reducing their positions, and 40 closing their positions.

Holders
284
Holders Change
-2
Holders Change %
-0.7%
% of All Funds
4.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
41
Increased
99
Reduced
106
Closed
40
Calls
$14.2M
Puts
$6.27M
Net Calls
+$7.9M
Net Calls Change
+$24.9M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$104M
2
Impax Asset Management Group
2
Impax Asset Management Group
United Kingdom
$48.5M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$253M
4
DM
4
Deerfield Management
New York
$34.8M
5
RP
5
Riverbridge Partners
Minnesota
$158M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$33.5M
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$24.2M
3
Twin Tree Management
3
Twin Tree Management
Texas
$0
4
Amundi
4
Amundi
France
$13M
5
Ameriprise
5
Ameriprise
Minnesota
$105M
Name Market Value Shares Shares
Change 		Shares
Change %
HM
326
Harvest Management
New York
– – – –
SIC
327
SJS Investment Consulting
Ohio
$0 4 +4 New
SCA
328
Stonebridge Capital Advisors
Minnesota
$0 5 +5 New
10 11 12 13
14